Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination

Journal of Medical Virology

Volumn 62, Issue 1, 2000, Pages 46-51

  Furuta, Yasushi ^a   Ohtani, Fumio ^a   Fukuda, Satoshi ^a   Inuyama, Yukio ^a   Nagashima, Kazuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Immunocompetent; Immunocompromised patient; Reinfection; Saliva; The elderly

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN A ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CHICKENPOX; CHILD; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; NONHUMAN; REINFECTION; VACCINATION; VARICELLA ZOSTER VIRUS;

AGED; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMAN; IMMUNITY, MUCOSAL; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN A, SECRETORY; MIDDLE AGE; NEUTRALIZATION TESTS; SALIVA; SUPPORT, NON-U.S. GOV'T; VACCINATION;

DNA VIRUSES; HERPES; HERPES ZOSTER; HUMAN HERPESVIRUS 3;

EID: 0033859240     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200009)62:1<46::AID-JMV8>3.0.CO;2-Y     Document Type: Article

References (28)

1. Varicella vaccine trials in healthy children: A summary of comparative and follow-up studies
2. Studies on neutralization of varicella-zoster virus and serological follow-up of cases of varicella and zoster
3. Long-term protective immunity of recipients of the Oka strain of varicella vaccine
4. Varicella vaccine: The Japanese experience
5. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine
6. Antibody response to varicella-zoster virus after natural or vaccine-induced infection
7. Immunity at mucosal surfaces
8. Over five-years follow up of Oka/Merck varicella vaccine recipients in 465 infants and adolescents
9. An investigation into the effect of the IgG antibody system on the susceptibility of IgA-deficient patients to respiratory tract infections
10. Variation on a theme by Fenner: The pathogenesis of chickenpox
11. Specific IgM and IgG antibodies in IgA deficiency
12. A long-term prospective study of varicella vaccine in healthy children
13. Recurrent varicella-zoster virus infections in apparently immunocompetent children
14. The mucosal immune system: Features of inductive and effector sites to consider in mucosal immunization and vaccine development
15. Risk factor for breakthrough varicella in healthy children
16. Polymeric immunoglobulin receptor expressed in MDCK cells transcytoses IgA
17. Lymphocyte associated viremia in varicella
18. Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination
19. Detection of varicella-zoster virus DNA in blood of children with varicella
20. Virus antibody levels in IgA deficiency
21. Reactivation of chickenpox contracted in infancy
22. Recurrent chickenpox after natural infection
23. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine
24. Cell-mediated immune responses after immunization of healthy seronegative children with varicella vaccine: Kinetics and specificity
25. Live Oka/Merck varicella vaccine in healthy children: Further clinical and laboratory assessment
26. Modified cases of chickenpox after varicella vaccination: Correlation of protection with antibody response
27. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation
28. Efficacy of high-titer attenuated varicella vaccine in healthy young children